COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Protein Kinases in Drug Discovery - 1st Edition - ISBN: 9780323853132

Protein Kinases in Drug Discovery, Volume 124

1st Edition

Editor: Rossen Donev
Hardcover ISBN: 9780323853132
Imprint: Academic Press
Published Date: 1st March 2021
Page Count: 350
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Transport Proteins and AMPs: Implications in Human Disease
Shailza Singh
2. Protein kinase CK2 inhibition as a pharmacological strategy
Maria Ruzzene
3. Emerging role of Protein kinase in diabetes mellitus: From Mechanism to therapy
Imtaiyaz Hassan
4. Dual Roles of ATP-binding site in Protein Kinases: Orthosteric inhibition and Allosteric Regulation
Shaoyong Lu
5. Pseudokinases in drug discovery and development: progress, challenges and future prospects
G Rajanikant
6. Comparison of knowledge-based vs combinatorial peptide library approaches for the identification of protein kinase substrates
Amaury Fernández-Montalván
7. Assessment of sub-kinomes using peptide arrays: A novel platform connecting protein kinase activity and systems pharmacology approaches
Robert Mccullumsmith
8. Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases
Carolina Horta Andrade
9. Targeting malaria protein kinases
Fabio Costa
10. Yeast-based high-throughput screen for discovery of kinase inhibitors as antiparasitic drug candidates
Elizabeth Bilsland
11. Predicting nucleophilic hotspots in protein kinases
Jana Shen
12. Structural studies of full-length kinase receptors: Opportunities for drug design
Ho Leung Ng


Description

Protein Kinases in Drug Discovery, Volume 124 discusses the latest information on protein kinases and how they modify other proteins by chemically adding phosphate groups to them. New chapters in this release include Transport Proteins and AMPs: Implications in Human Disease, Protein kinase CK2 inhibition as a pharmacological strategy, Emerging role of Protein kinase in diabetes mellitus: From Mechanism to therapy, Dual Roles of ATP-binding site in Protein Kinases: Orthosteric inhibition and Allosteric Regulation, Pseudokinases in drug discovery and development: progress, challenges and future prospects, Comparison of knowledge-based vs. combinatorial peptide library approaches for the identification of protein kinase substrates, and more.

Key Features

  • Contains timely chapters written by well-renown authorities in their field
  • Includes a number of high-quality illustrations, figures and tables, and targets a very wide audience of specialists, researchers and students
  • Integrates experimental and computational methods for studying the role of protein kinases in different diseases, along with sections on the design of suitable protein kinase inhibitors for use in the treatment of patients

Readership

Protein chemists, molecular cell biologists, immunologists, structural biologists, computational biochemists, medical doctors, pharmacologists and other researchers working in the field of transport proteins and drug design. Medical, biology and pharmacology students specializing in this field


Details

No. of pages:
350
Language:
English
Copyright:
© Academic Press 2021
Published:
1st March 2021
Imprint:
Academic Press
Hardcover ISBN:
9780323853132

Ratings and Reviews


About the Editor

Rossen Donev

Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Affiliations and Expertise

Swansea University, UK